Ernexa Therapeutics Inc — 재무제표 (NASDAQ:ERNA) | MetaTrader

전체 차트 열기

Financials

개요 성명 통계

총자산 3.75 M32.43 M22.28 M49.13 M5.27 M5.83 M 총 부채 2.89 M25.93 M10.17 M46.9 M3.57 M3.43 M 자본금 총액 851 K6.5 M12.11 M2.23 M1.7 M2.4 M 총 부채 및 주주자본 3.75 M32.43 M22.28 M49.13 M5.27 M5.83 M 총부채 2.05 M——6.77 M0— 순부채 1.28 M——-802 K-1.73 M—

뉴스

Ernexa Therapeutics, 주요 주주 Cherington, 2백만 달러 주식 매입

Ernexa therapeutics ten percent owner Cherington buys $2m in stock

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.47%

일본, 유망 바이오텍 그룹에 Eranexa Therapeutics 선정

Japanese trade program selects Ernexa Therapeutics among elite biotech group

Why Penguin Solutions Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket - AAR (NYSE:AIR), Alpha Modus Holdings (NASDAQ:AMOD)

Ernexa receives FDA alignment for ovarian cancer cell therapy

Ernexa Therapeutics, ASH 회의 발표 후 주가 하락

Ernexa Therapeutics stock falls after ASH meeting presentation

Ernexa reports promising preclinical data for cancer cell therapy

Ernexa 테라퓨틱스, 위너 박사를 자문위원회에 임명

Ernexa Therapeutics appoints oncologist Dr. Winer to advisory board